Flubendazole is a benzimidazole compound that inhibits microtubule polymerization; it exhibits anti-parasitic and anticancer chemotherapeutic activities. Flubendazole displays anti-helminthic benefit against Haemonchus and Trichomonas. When co-administered with vinblastine, flubendazole decreases in vitro cell viability and in vivo tumor growth in leukemia and myeloma models.
| Cas No. | 31430-15-6 |
|---|---|
| Purity | ≥98% |
| Formula | C16H12FN3O3 |
| Formula Wt. | 313.28 |
| Chemical Name | [5-(4-Fluorobenzoyl)-1H-benzimidazole-2-yl]carbamic acid methyl ester |
| IUPAC Name | methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate |
| Synonym | Flubenol; Flumoxal; Flumoxane; Fluvermal |
| Melting Point | 260°C |
| Solubility | Insoluble in water. |
| Appearance | White or Almost White Powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | F4679 MSDS PDF |
|---|---|
| Info Sheet | F4679 Info Sheet PDF |
Spagnuolo PA, Hu J, Hurren R, et al. The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood. 2010 Jun 10;115(23):4824-33. PMID: 20348394.
Juliano C, Martinotti MG, Cappuccinelli P. "In vitro" effect of microtubule inhibitors on Trichomonas vaginalis. Microbiologica. 1985 Jan;8(1):31-42. PMID: 3871893.
